Immersive virtual reality training to improve thinking and memory in adults with metabolic syndrome
Official title: Multimodal Immersive Virtual Reality Training for Improving Cognition in Adults With Metabolic Syndrome: A Randomized Clinical Trial
Run by Consorci Sanitari de Terrassa · NCT07040748 · Data updated 2026-11-12
This project will try immersive virtual reality sessions that combine cognitive exercises and physical activity to see if they improve thinking and memory in middle-aged adults with metabolic syndrome who report cognitive complaints.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 70 Years |
| Sex | All |
| Enrollment | 84 (estimated) |
| Sponsor | Consorci Sanitari de Terrassa Academic / other |
| Locations | 1 site (Terrassa) |
| Status | Recruiting |
| Started | March 1, 2025 |
| Main results expected | April 1, 2027 |
| Study ends | April 1, 2027 |
| Registry record updated | October 23, 2026 |
| Trial ID | NCT07040748 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are Spanish- or Catalan-speaking adults aged 45–70 who meet metabolic syndrome criteria and report subjective cognitive complaints.
✕Probably not a fit
People with suspected dementia, significant psychiatric or neurological disorders, major systemic illnesses, or who cannot attend in-person sessions or speak Spanish/Catalan are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, single-blind trial will enroll 84 adults aged 45–70 with metabolic syndrome and subjective cognitive complaints and assign them to either the Virtual-METS program or treatment-as-usual. The Virtual-METS program delivers group immersive virtual reality sessions combining cognitive training and physical exercise twice weekly for 12 weeks (24 sessions total). Primary outcomes are cognitive performance measured by a neuropsychological battery and eye-tracking tasks, with secondary outcomes of treatment adherence, daily functioning, and quality of life assessed at baseline, post-treatment, and six months. Ophthalmologic exams, carotid Doppler ultrasound, and panels of blood-based and gut-derived biomarkers will also be collected to explore physiological mechanisms.
Why it matters
Potential benefit: If successful, this non-drug program could improve cognitive function and daily functioning in people with metabolic syndrome while offering a more engaging and accessible therapy.
How similar studies have gone: Previous small trials and multimodal exercise-plus-cognitive programs have shown promising but mixed effects on cognition, and immersive VR approaches are emerging with encouraging early results but limited large-scale evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Demonstrated criteria for the MetS: central obesity (waist circumference ≥ 94 cm for men or ≥ 80 cm for women) and at least 2 of the criteria described as follow: Triglycerides ≥ 150 mg/dl or specific treatment of this lipid disorder; HDL-C \< 40 mg/dl (men) or \< 50 mg/dl (women) or specific treatment of this lipid disorder; Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg or previously diagnosed hypertension treatment; Basal glycemia ≥ 100 mg/dl or type 2 diabetes previously diagnosed). * Age: between 45 and 70 years old. * Subjective cognitive complaints: Subjective Cognitive Decline Questionnaire (≥ 7). * Ability to fully understand and speak Spanish or Catalan. Exclusion Criteria: * Confirmed or suspicion of dementia (MMSE\<24). * Diagnosis of severe psychiatric, neurological, developmental disorders, systemic pathologies, hematological, hormonal, nutritional pathology, and/or neoplasm that are known to cause cognitive deficits. * Other severe comorbidities considered a probable bias for the study: a cardiac history of unstable angina, recent myocardial infarction within the last 3 months, congestive heart failure, significant heart valve dysfunction, or unstable hypertension; taking medications that could negatively affect cognitive function. * Physical, motor, or sensory alterations that impede the neuropsychological examination or the rehabilitation program.
Where it's running
-
Consorci Sanitari de Terrassa
Terrassa, Spain Recruiting
Study contacts
- Study coordinator: Maite Garolera
- Email: mgarolera@cst.cat
- Phone: +34937310007
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Fulvic acid supplements for metabolic syndrome
This study tests whether 50 mg or 100 mg of fulvic acid daily for 12 weeks can help people with metabolic syndrome or prediabetes.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Low-Calorie Diet in adolescents with Familial Mediterranean Fever and metabolic syndrome
A group of adolescents with both FMF and metabolic syndrome will try a low-calorie diet for 3 months to see if it helps manage metabolic symptoms.
-
Exercise for Metabolic Syndrome and Fatty Liver in Adolescent Girls with Celiac Disease
This study tests whether a 3-month walking program helps improve metabolic syndrome and fatty liver in adolescent females with celiac disease.
-
Longevity Metrics AI/ML Development Study
Researchers are testing AI models that score health screening tests and predict outcomes like life expectancy for adults, using ongoing follow-up data.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.